The protective effects of granulocyte-macrophage colony-stimulating factor against radiation-induced lung injury. 2020

Dan Hu, and Yan Zhang, and Ruiqi Cao, and Yuying Hao, and Xiaoye Yang, and Tiantian Tian, and Jiandong Zhang
Department of Oncology, The First Affiliated Hospital of Shandong First Medical University & Shandong Provincial Qianfoshan Hospital, Jinan, China.

BACKGROUND Radiation-induced lung injury (RILI) is a common complication of thoracic cancer radiation therapy. Currently, there is no effective treatment for RILI. RILI is associated with chronic inflammation, this injury is perpetuated by the stimulation of chemokines and proinflammatory cytokines. Recent studies have demonstrated that granulocyte-macrophage colony-stimulating factor (GM-CSF) plays a pivotal role in inflammation and fibrosis. This study aimed to investigate the protective effect of GM-CSF against the development of RILI in lung tissue. METHODS First, a single fraction of radiation at a dose of 16 Gy was targeted at the entire thorax of wild-type (WT) C57BL/6 mice and GM-CSF-/- mice to induce RILI. Second, we detected the radioprotective effects of GM-CSF by measuring the inflammatory biomarkers and fibrosis alteration on radiated lung tissues. Furthermore, we investigated the potential mechanism of GM-CSF protective effects in RILI. RESULTS The GM-CSF-/- mice sustained more severe RILI than the WT mice. RILI was significantly alleviated by GM-CSF treatment. Intraperitoneally administered GM-CSF significantly inhibited inflammatory cytokine production and decreased epithelial-mesenchymal transition (EMT) in the RILI mouse model. CONCLUSIONS GM-CSF was shown to be an important modulator of RILI through regulating inflammatory cytokines, which provides a new strategy for the prevention and treatment of RILI.

UI MeSH Term Description Entries

Related Publications

Dan Hu, and Yan Zhang, and Ruiqi Cao, and Yuying Hao, and Xiaoye Yang, and Tiantian Tian, and Jiandong Zhang
October 2013, Archives of pharmacal research,
Dan Hu, and Yan Zhang, and Ruiqi Cao, and Yuying Hao, and Xiaoye Yang, and Tiantian Tian, and Jiandong Zhang
October 2013, International journal of critical illness and injury science,
Dan Hu, and Yan Zhang, and Ruiqi Cao, and Yuying Hao, and Xiaoye Yang, and Tiantian Tian, and Jiandong Zhang
April 2007, Oncology reports,
Dan Hu, and Yan Zhang, and Ruiqi Cao, and Yuying Hao, and Xiaoye Yang, and Tiantian Tian, and Jiandong Zhang
January 1991, Radiobiologiia,
Dan Hu, and Yan Zhang, and Ruiqi Cao, and Yuying Hao, and Xiaoye Yang, and Tiantian Tian, and Jiandong Zhang
July 1992, The New England journal of medicine,
Dan Hu, and Yan Zhang, and Ruiqi Cao, and Yuying Hao, and Xiaoye Yang, and Tiantian Tian, and Jiandong Zhang
July 1992, The New England journal of medicine,
Dan Hu, and Yan Zhang, and Ruiqi Cao, and Yuying Hao, and Xiaoye Yang, and Tiantian Tian, and Jiandong Zhang
January 2000, Radiation medicine,
Dan Hu, and Yan Zhang, and Ruiqi Cao, and Yuying Hao, and Xiaoye Yang, and Tiantian Tian, and Jiandong Zhang
January 1990, Immunology series,
Dan Hu, and Yan Zhang, and Ruiqi Cao, and Yuying Hao, and Xiaoye Yang, and Tiantian Tian, and Jiandong Zhang
January 1990, Biotherapy (Dordrecht, Netherlands),
Dan Hu, and Yan Zhang, and Ruiqi Cao, and Yuying Hao, and Xiaoye Yang, and Tiantian Tian, and Jiandong Zhang
July 2010, Nihon rinsho. Japanese journal of clinical medicine,
Copied contents to your clipboard!